Let’s dig into the relative performance of Abbott Laboratories (NYSE:ABT) and its peers as we unravel the now-completed Q4 medical devices & supplies - diversified earnings season. The medical devices ...

Boston Scientific (NYSE:BSX) experienced a 6% decline in stock price over the last quarter, amid a period of market uncertainty driven by new tariffs imposed by the U.S. and retaliatory measures from ...

Investing.com -- Boston Scientific (NYSE:BSX) reported fiscal Q4 2024 results that surpassed analyst expectations. The company's shares swung between gains and losses in premarket trading Wednesday.

In this article, we are going to take a look at where Boston Scientific Corporation (NYSE:BSX) stands against other best healthcare stocks to invest in. Healthcare stocks experienced a challenging ...

It has been about a month since the last earnings report for Boston Scientific (BSX). Shares have lost about 4% in that time frame, outperforming the S&P 500. Will the recent negative trend ...

Truist lowered the firm’s price target on Boston Scientific (BSX) to $113 from $120 and keeps a Buy rating on the shares as part of a broad ...